|
| |
medimmune and human papillomavirus Pages on BioPortfolio:
BioPortfolio - MedImmune
MedImmune Patents:. US Patent No. Title. 6737063, FimH adhesin proteins and methods of use. 6908613, Chimeric human papillomavirus (HPV) L1 molecules and
...
http://www.bioportfolio.com/biocorporate/6860-MedImmune.html...
|
BioPortfolio.com - BioWeb Intermittent Claudication Search
... Interferon for genital warts (human papillomavirus) - [Medication] Top. .... MedImmune Oncology Complete a new search Drug Name (Proprietary ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - hpv medimmune patent
MedImmune expands its patent estate for reverse genetics with the .... MedImmune scientists present human papillomavirus (HPV) vaccine Phase 1 data in . ...
http://www.bioportfolio.com/search/hpv_medimmune_patent.html...
|
BioPortfolio - Medimmune, Incorporated. - Profile
Medimmune, Incorporated. Patents:. • 6737063- FimH adhesin proteins and methods of use. • 6908613- Chimeric human papillomavirus (HPV) L1 molecules and uses ...
http://www.bioportfolio.com/biocorporate/32934-Medimmune,%2B...
|
Immunotherapies and Vaccines for Cancer and Infectious Diseases ...
Human Papillomavirus—Infectious Disease Prophylactic Vaccine for Prevention of Cancer: ... Medical and Scientific Affairs, MedImmune, Gaithersburg, MD ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1148.html...
|
BioPortfolio - ICO Incorporated - Profile
Epidemiology and natural history of human papillomavirus infections and type- specific ... MedImmune Presents Data Highlighting its Progressive Inflammatory
...
http://www.bioportfolio.com/biocorporate/5171-ICO+Incorporat...
|
BioPortfolio - CSL Limited - Profile
MedImmune Licenses Reverse Genetics Technology to Hungary's Omninvest for Use in Influenza ... 6306397- Variants of human papilloma virus antigens ...
http://www.bioportfolio.com/biocorporate/21490-CSL+Limited.p...
|
BioPortfolio - Viral Load - InDepth
Prevalence of high-risk human papillomavirus infection in different ... 1Respiratory, Inflammation, and Autoimmunity Group, MedImmune,- J Infect Dis.
...
http://www.bioportfolio.com/indepth/Viral_Load.pdf...
|
Anti-Infectives World Markets 2nd Edition Vol. I-III Complete Series
Human Immunodeficiency Virus (HIV) Human Papillomavirus (HPV) Influenza Respiratory Syncytial Virus (RSV) ... MedImmune, Inc. Merck & Company, Inc. ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_763.html...
|
Biopharmaceutical Products in the U.S. and European Markets
Human Papillomavirus (HPV) Vaccines ..... Influenza Vaccine, H5N1/MedImmune .... Page 1109 • Blood Products, Human . . . Protein A/Prosorba ...
http://www.bioportfolio.com/cgi-bin/acatalog/Biopharma_US-EU...
|
Results from other life science and pharmaceutical sites:
MedImmune | About MedImmune | Company History
MedImmune scientists present human papillomavirus (HPV) vaccine Phase 1 data in Barcelona at International Papillomavirus Conference. ...
http://www.medimmune.com/about/history.asp...
|
HPV vaccine MedImmune/GlaxoSmithKline Andreas Billich
212925 MedImmune in-licenses key human papillomavirus vaccine ... human papillomavirus vaccine candidate. MedImmune PRESS RELEASE. 1997 February 03 ...
http://www.biomedcentral.com/content/pdf/cd-479799.pdf...
|
MedImmune | R&D Pipeline | R&D Pipeline Overview
MedImmune and GlaxoSmithKline (GSK) are developing a vaccine to prevent cervical cancer, a disease primarily caused by human papillomavirus (HPV) infection. ...
http://www.medimmune.com/pipeline/hpvaccine.asp...
|
BioPortfolio - MedImmune
MedImmune Patents:. US Patent No. Title. 6737063, FimH adhesin proteins and methods of use. 6908613, Chimeric human papillomavirus (HPV) L1 molecules and
...
http://www.bioportfolio.com/biocorporate/6860-MedImmune.html...
|
MedImmune | About | Strategic Alliances
MedImmune and GSK are developing a vaccine against human papillomavirus (“HPV”) to prevent cervical cancer under a strategic alliance. ...
http://www.medimmune.com/about/company/alliances.asp...
|
HPV vaccine MedImmune/GlaxoSmithKline. [Curr Opin Investig Drugs ...
MedImmune, in collaboration with GlaxoSmithKline, is developing a vaccine ... Human papillomavirus vaccines in development: if they're successful in ...
http://www.ncbi.nlm.nih.gov/pubmed/12669384...
|
MedImmune | Press Room | Press Room Overview
MedImmune Reconfirms 2009 Financial Targets of $2 Billion in Revenues and $2.00 in ... We also expect royalties from our human papillomavirus vaccine ...
http://www.medimmune.com/press/fullstory.asp?reqid=939548&yr...
|
BioPortfolio - Medimmune, Incorporated. - Profile
Medimmune, Incorporated. Patents:. • 6737063- FimH adhesin proteins and methods of use. • 6908613- Chimeric human papillomavirus (HPV) L1 molecules and uses ...
http://www.bioportfolio.com/biocorporate/32934-Medimmune,%2B...
|
MedImmune | Press Room | Press Room Overview
MedImmune Grants SmithKline Beecham an Exclusive Worldwide License to ... positive in the ongoing development program for our human papillomavirus vaccine
, ...
http://www.medimmune.com/press/fullstory.asp?reqid=366261&yr...
|
Physicians Begin Testing First Human Papillomavirus Vaccine
Physicians Begin Testing First Human Papillomavirus Vaccine ... with MedImmune on the technology are scientists from Georgetown University, the German ...
http://www.urmc.rochester.edu/PR/current_research/Cervical_C...
|
|
